Cargando…
Controlling aggregation of cholesterol-modified DNA nanostructures
DNA nanotechnology allows for the design of programmable DNA-built nanodevices which controllably interact with biological membranes and even mimic the function of natural membrane proteins. Hydrophobic modifications, covalently linked to the DNA, are essential for targeted interfacing of DNA nanost...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868430/ https://www.ncbi.nlm.nih.gov/pubmed/31642494 http://dx.doi.org/10.1093/nar/gkz914 |
_version_ | 1783472269364822016 |
---|---|
author | Ohmann, Alexander Göpfrich, Kerstin Joshi, Himanshu Thompson, Rebecca F Sobota, Diana Ranson, Neil A Aksimentiev, Aleksei Keyser, Ulrich F |
author_facet | Ohmann, Alexander Göpfrich, Kerstin Joshi, Himanshu Thompson, Rebecca F Sobota, Diana Ranson, Neil A Aksimentiev, Aleksei Keyser, Ulrich F |
author_sort | Ohmann, Alexander |
collection | PubMed |
description | DNA nanotechnology allows for the design of programmable DNA-built nanodevices which controllably interact with biological membranes and even mimic the function of natural membrane proteins. Hydrophobic modifications, covalently linked to the DNA, are essential for targeted interfacing of DNA nanostructures with lipid membranes. However, these hydrophobic tags typically induce undesired aggregation eliminating structural control, the primary advantage of DNA nanotechnology. Here, we study the aggregation of cholesterol-modified DNA nanostructures using a combined approach of non-denaturing polyacrylamide gel electrophoresis, dynamic light scattering, confocal microscopy and atomistic molecular dynamics simulations. We show that the aggregation of cholesterol-tagged ssDNA is sequence-dependent, while for assembled DNA constructs, the number and position of the cholesterol tags are the dominating factors. Molecular dynamics simulations of cholesterol-modified ssDNA reveal that the nucleotides wrap around the hydrophobic moiety, shielding it from the environment. Utilizing this behavior, we demonstrate experimentally that the aggregation of cholesterol-modified DNA nanostructures can be controlled by the length of ssDNA overhangs positioned adjacent to the cholesterol. Our easy-to-implement method for tuning cholesterol-mediated aggregation allows for increased control and a closer structure–function relationship of membrane-interfacing DNA constructs — a fundamental prerequisite for employing DNA nanodevices in research and biomedicine. |
format | Online Article Text |
id | pubmed-6868430 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-68684302019-11-27 Controlling aggregation of cholesterol-modified DNA nanostructures Ohmann, Alexander Göpfrich, Kerstin Joshi, Himanshu Thompson, Rebecca F Sobota, Diana Ranson, Neil A Aksimentiev, Aleksei Keyser, Ulrich F Nucleic Acids Res Synthetic Biology and Bioengineering DNA nanotechnology allows for the design of programmable DNA-built nanodevices which controllably interact with biological membranes and even mimic the function of natural membrane proteins. Hydrophobic modifications, covalently linked to the DNA, are essential for targeted interfacing of DNA nanostructures with lipid membranes. However, these hydrophobic tags typically induce undesired aggregation eliminating structural control, the primary advantage of DNA nanotechnology. Here, we study the aggregation of cholesterol-modified DNA nanostructures using a combined approach of non-denaturing polyacrylamide gel electrophoresis, dynamic light scattering, confocal microscopy and atomistic molecular dynamics simulations. We show that the aggregation of cholesterol-tagged ssDNA is sequence-dependent, while for assembled DNA constructs, the number and position of the cholesterol tags are the dominating factors. Molecular dynamics simulations of cholesterol-modified ssDNA reveal that the nucleotides wrap around the hydrophobic moiety, shielding it from the environment. Utilizing this behavior, we demonstrate experimentally that the aggregation of cholesterol-modified DNA nanostructures can be controlled by the length of ssDNA overhangs positioned adjacent to the cholesterol. Our easy-to-implement method for tuning cholesterol-mediated aggregation allows for increased control and a closer structure–function relationship of membrane-interfacing DNA constructs — a fundamental prerequisite for employing DNA nanodevices in research and biomedicine. Oxford University Press 2019-12-02 2019-10-23 /pmc/articles/PMC6868430/ /pubmed/31642494 http://dx.doi.org/10.1093/nar/gkz914 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Synthetic Biology and Bioengineering Ohmann, Alexander Göpfrich, Kerstin Joshi, Himanshu Thompson, Rebecca F Sobota, Diana Ranson, Neil A Aksimentiev, Aleksei Keyser, Ulrich F Controlling aggregation of cholesterol-modified DNA nanostructures |
title | Controlling aggregation of cholesterol-modified DNA nanostructures |
title_full | Controlling aggregation of cholesterol-modified DNA nanostructures |
title_fullStr | Controlling aggregation of cholesterol-modified DNA nanostructures |
title_full_unstemmed | Controlling aggregation of cholesterol-modified DNA nanostructures |
title_short | Controlling aggregation of cholesterol-modified DNA nanostructures |
title_sort | controlling aggregation of cholesterol-modified dna nanostructures |
topic | Synthetic Biology and Bioengineering |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868430/ https://www.ncbi.nlm.nih.gov/pubmed/31642494 http://dx.doi.org/10.1093/nar/gkz914 |
work_keys_str_mv | AT ohmannalexander controllingaggregationofcholesterolmodifieddnananostructures AT gopfrichkerstin controllingaggregationofcholesterolmodifieddnananostructures AT joshihimanshu controllingaggregationofcholesterolmodifieddnananostructures AT thompsonrebeccaf controllingaggregationofcholesterolmodifieddnananostructures AT sobotadiana controllingaggregationofcholesterolmodifieddnananostructures AT ransonneila controllingaggregationofcholesterolmodifieddnananostructures AT aksimentievaleksei controllingaggregationofcholesterolmodifieddnananostructures AT keyserulrichf controllingaggregationofcholesterolmodifieddnananostructures |